The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry
Arla Foods Ingredients has unveiled a new whey protein hydrolysate, Lacprodan DI-3092, designed to address key challenges in peptide-based medical nutrition.
The ingredient delivers 10g of protein per 100ml, which according to the company it is "significantly higher" than the standard 6-7g found in comparable products. It is designed to minimise bitterness, addressing a common challenge in medical nutrition.
Whey protein hydrolysates are created through an enzymatic process that breaks protein down into peptides, making them easier to digest. They are particularly useful for patients with impaired gastrointestinal function or nutrient absorption.
Arla has developed two prototypes with Lacprodan DI-3092: a ready-to-drink beverage and a ready-to-mix powder. Both contain 10g of protein per 100ml and feature a mild taste and low viscosity.
Mads Dyrvig, head of sales development for specialised nutrition at Arla Foods Ingredients, said: “Whey protein hydrolysates are essential for peptide-based medical nutrition but there are three key challenges in the category. The first is to improve taste and texture, which is important to ensure patient compliance. The second is to go higher in protein and the third is to do that using a high-quality protein source. Lacprodan DI-3092 – our best-tasting whey protein hydrolysate yet – overcomes all three challenges.”
Lacprodan DI-3092 has a high degree of hydrolysis (16-22%) and low lactose content, and is UHT-stable, making it suitable for both direct and indirect heat treatment.
#ArlaFoodsIngredients #ingredient #wheyprotein #dairy
